Display options
Share it on

Front Cell Neurosci. 2015 May 18;9:148. doi: 10.3389/fncel.2015.00148. eCollection 2015.

Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer's disease: a pilot study.

Frontiers in cellular neuroscience

Danira Toral-Rios, Diana Franco-Bocanegra, Oscar Rosas-Carrasco, Francisco Mena-Barranco, Rosa Carvajal-García, Marco Antonio Meraz-Ríos, Victoria Campos-Peña

Affiliations

  1. Departamento de Fisiología Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados Mexico City, Mexico.
  2. Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México Mexico City, Mexico.
  3. Instituto Nacional de Geriatría Mexico City, Mexico.
  4. Hospital Regional de Alta Especialidad de Ixtapaluca Estado de México, Mexico.
  5. Centro Geriátrico SINANK'AY Querétaro, Mexico.
  6. Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados Mexico City, Mexico.
  7. Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez Mexico City, Mexico.

PMID: 26041990 PMCID: PMC4435067 DOI: 10.3389/fncel.2015.00148

Abstract

Amyloid peptide is able to promote the activation of microglia and astrocytes in Alzheimer's disease (AD), and this stimulates the production of pro-inflammatory cytokines. Inflammation contributes to the process of neurodegeneration and therefore is a key factor in the development of AD. Some of the most important proteins involved in AD inflammation are: clusterin (CLU), complement receptor 1 (CR1), C reactive protein (CRP), tumor necrosis factor α (TNF-α), the interleukins 1α (IL-1α), 6 (IL-6), 10 (IL-10) and cyclooxygenase 2 (COX-2). In particular, COX-2 is encoded by the prostaglandin-endoperoxide synthase 2 gene (PTGS2). Since variations in the genes that encode these proteins may modify gene expression or function, it is important to investigate whether these variations may change the developing AD. The aim of this study was to determine whether the presence of polymorphisms in the genes encoding the aforementioned proteins is associated in Mexican patients with AD. Fourteen polymorphisms were genotyped in 96 subjects with AD and 100 controls; the differences in allele, genotype and haplotype frequencies were analyzed. Additionally, an ancestry analysis was conducted to exclude differences in genetic ancestry among groups as a confounding factor in the study. Significant differences in frequencies between AD and controls were found for the single-nucleotide polymorphism (SNP) rs20417 within the PTGS2 gene. Ancestry analysis revealed no significant differences in the ancestry of the compared groups, and the association was significant even after adjustment for ancestry and correction for multiple testing, which strengthens the validity of the results. We conclude that this polymorphism plays an important role in the development of the AD pathology and further studies are required, including their proteins.

Keywords: Alzheimer’s disease; cyclooxygenase 2; genetic ancestry; inflammation; prostaglandin-endoperoxide synthase

References

  1. Neurosci Lett. 1995 Dec 29;202(1-2):17-20 - PubMed
  2. Am J Hum Genet. 2007 May;80(5):921-30 - PubMed
  3. Ann N Y Acad Sci. 2003 Jun;991:272-7 - PubMed
  4. Mediators Inflamm. 2013;2013:480739 - PubMed
  5. J Aging Health. 2011 Oct;23(7):1050-74 - PubMed
  6. J Res Med Sci. 2011 Aug;16(8):1006-13 - PubMed
  7. Bioinformatics. 2006 Aug 1;22(15):1928-9 - PubMed
  8. Neurobiol Aging. 2007 Sep;28(9):1361-6 - PubMed
  9. Genetics. 2000 Jun;155(2):945-59 - PubMed
  10. Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):307-15 - PubMed
  11. Hum Hered. 2013;76(1):28-35 - PubMed
  12. Lancet Neurol. 2008 Sep;7(9):812-26 - PubMed
  13. Arch Neurol. 2001 Mar;58(3):487-92 - PubMed
  14. Ann Neurol. 2000 Nov;48(5):817-9 - PubMed
  15. J Neuroinflammation. 2011 Aug 11;8:96 - PubMed
  16. J Neuroinflammation. 2009 Aug 23;6:22 - PubMed
  17. Genetics. 2003 Jun;164(2):747-65 - PubMed
  18. Brain Res. 1999 Jun 5;830(2):226-36 - PubMed
  19. Front Integr Neurosci. 2013 Aug 13;7:59 - PubMed
  20. Genet Epidemiol. 2005 Jul;29(1):76-86 - PubMed
  21. J Neurol. 2002 Sep;249(9):1242-5 - PubMed
  22. Brain Res. 2010 Aug 12;1348:216-21 - PubMed
  23. Neurosci Lett. 2006 Mar 13;395(3):240-3 - PubMed
  24. J Alzheimers Dis. 2010;21(1):1-14 - PubMed
  25. Am J Pathol. 1992 Jun;140(6):1389-99 - PubMed
  26. J Neuroinflammation. 2012 Jan 24;9:21 - PubMed
  27. Neuropsychiatr Dis Treat. 2015 Jan 30;11:243-56 - PubMed
  28. Neurobiol Aging. 2006 Feb;27(2):211-7 - PubMed
  29. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8729-32 - PubMed
  30. Bioinformatics. 2012 Oct 1;28(19):2537-9 - PubMed
  31. Forensic Sci Int Genet. 2008 Jun;2(3):e37-9 - PubMed
  32. Biomed Res Int. 2014;2014:908915 - PubMed
  33. J Neural Transm (Vienna). 2010 Aug;117(8):919-47 - PubMed
  34. Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044-8 - PubMed
  35. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1878-85 - PubMed
  36. Nat Rev Genet. 2011 Mar;12(3):167-78 - PubMed
  37. Neurosci Lett. 2007 May 18;418(3):262-5 - PubMed
  38. Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1458-63 - PubMed
  39. Nat Genet. 2009 Oct;41(10):1088-93 - PubMed
  40. Mol Biol Evol. 1998 Oct;15(10):1298-311 - PubMed
  41. J Leukoc Biol. 2006 Mar;79(3):596-610 - PubMed
  42. Eur J Hum Genet. 2005 Jul;13(7):840-8 - PubMed
  43. Dement Geriatr Cogn Disord. 2004;18(3-4):261-4 - PubMed
  44. Methods Mol Biol. 2012;850:77-102 - PubMed
  45. Cortex. 1999 Feb;35(1):57-72 - PubMed
  46. J Neurol. 2007 Jun;254(6):774-81 - PubMed
  47. J Biol Chem. 2004 Nov 19;279(47):49523-32 - PubMed
  48. Curr Alzheimer Res. 2011 Mar;8(2):156-63 - PubMed
  49. Bioinformatics. 2005 Jan 15;21(2):263-5 - PubMed
  50. Lancet. 2008 Aug 9;372(9637):464-74 - PubMed
  51. Hum Mutat. 2005 Jul;26(1):29-35 - PubMed
  52. Nat Genet. 2009 Oct;41(10):1094-9 - PubMed
  53. Neurobiol Aging. 2014 Oct;35(10):2249-62 - PubMed
  54. J Alzheimers Dis. 2010;19(2):551-7 - PubMed
  55. Brain Res. 2000 Dec 22;887(1):80-9 - PubMed
  56. Eur J Immunol. 2001 Aug;31(8):2357-61 - PubMed
  57. Expert Opin Investig Drugs. 2004 Aug;13(8):1033-44 - PubMed
  58. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):505-12 - PubMed
  59. J Alzheimers Dis. 2010;19(1):355-61 - PubMed
  60. J Alzheimers Dis. 2011;23(2):361-9 - PubMed
  61. Hum Genet. 2006 Jan;118(5):652-64 - PubMed
  62. Ann Neurol. 2001 Feb;49(2):176-85 - PubMed
  63. Nature. 2010 Oct 28;467(7319):1061-73 - PubMed
  64. Neuroscience. 1998 Nov;87(2):319-24 - PubMed
  65. Int Rev Psychiatry. 2008 Aug;20(4):332-43 - PubMed
  66. Biol Psychiatry. 2010 Nov 15;68(10):930-41 - PubMed
  67. Arch Neurol. 2010 Dec;67(12):1473-84 - PubMed
  68. J Alzheimers Dis. 2013;34(3):701-6 - PubMed
  69. PLoS One. 2011 Feb 24;6(2):e16616 - PubMed
  70. Ann Neurol. 2002 Aug;52(2):168-74 - PubMed
  71. Neurology. 1984 Jul;34(7):939-44 - PubMed
  72. Mol Neurobiol. 2015;51(3):1017-23 - PubMed
  73. Neurobiol Aging. 2008 Jun;29(6):856-60 - PubMed

Publication Types